J. Masura et al., CATHETER CLOSURE OF MODERATE-SIZED TO LARGE-SIZED PATENT DUCTUS-ARTERIOSUS USING THE NEW AMPLATZER DUCT OCCLUDER - IMMEDIATE AND SHORT-TERMRESULTS, Journal of the American College of Cardiology, 31(4), 1998, pp. 878-882
Objectives. The aim of this study was to assess the immediate and shor
t term results of anterograde catheter closure of a moderate-to large-
sized patent ductus arteriosus (PDA) using the new self-expandable, re
spositionable Amplatzer duct occluder (ADO) device. Background. Transc
atheter closure of a PDA using devices or coils is technically challen
ging and may be accompanied by a 38% incidence of residual shunts. Met
hods. Twenty-four patients (6 male, 18 female) underwent attempted tra
nscatheter closure of a PDA using the ADO at a median age of 3.8 years
(range 0.4 to 48) and a median weight of 15.5 kg (range 6 to 70). The
mean PDA diameter at its narrowest segment was 3.7 +/- 1.5 mm. A 6F l
ong sheath was used for delivery of the ADO. Follow up evaluation was
performed with color flow mapping of the main pulmonary artery within
24 h and at 1 and 3 months after closure. Results. Twenty three of the
24 patients had successful device placement, Angiography showed that
7 patients had complete immediate closure, 14 had a trace shunt (foami
ng through the device with no jet), and 2 had a small residual shunt (
with a jet). Within 24 h, color Doppler revealed complete closure in a
ll patients, The unsuccessful attempt was during an initial trial with
a prototype that has been modified. The median fluoroscopy time was 1
3.5 min (range 6.3 to 47). All patients were discharged home the next
day, There were no complications, Of the 23 patients, 21 completed the
1-month follow-up, all (95% confidence interval [CI] 86% to 100%) wit
h complete closure, and 18 of 23 patients completed the 3-month follow
-up, also all (95% CI 83% to 100%) with complete closure. Conclusions.
Anterograde transcatheter closure using the new ADO is an effective t
herapy for patients with a PDA diameter up to 6 mm, Further clinical t
rials are underway, (C) 1998 by the American College of Cardiology.